Twelve-Month, Randomized, Controlled Trial of Bimatoprost 0.01%, 0.0125%, and 0.03% in Patients with Glaucoma or Ocular Hypertension
Autor: | Katz, L. Jay, Cohen, John S., Batoosingh, Amy L., Felix, Carlos, Shu, Vincent, Schiffman, Rhett M. |
---|---|
Zdroj: | In American Journal of Ophthalmology 2010 149(4):661-671 |
Databáze: | ScienceDirect |
Externí odkaz: |